Table 1 Overview of the study dataset showing more than 118,000 days of CGM data with over 2.2 million blood glucose samples from 108 young adults with type 1 diabetes. \(\phantom{0}^*\)Hemoglobin A1 C values collected via the mail-in AccuBase A1c test kit.
Attributes | Mean ± SD | Range | Not Available | |
|---|---|---|---|---|
Demographics | Total no. of participants | 108 | \(\backslash\) | \(\backslash\) |
Age (yrs.) | 23 ± 3 | 19 - 29 | \(\backslash\) | |
Male/Female | 26/78 | \(\backslash\) | 4 | |
White/Black/Others | 77/12/7 | \(\backslash\) | 12 | |
Time since T1D diagnosis (yrs.) | 11.5 ± 5.3 | 2.4 - 27.0 | 2 | |
Hemoglobin A1C (%)\(\phantom{0}^*\) | 8.4 ± 1.3 | 6.3 - 14.4 | 14 | |
Insulin pump/Multiple daily injections | 88/20 | \(\backslash\) | \(\backslash\) | |
Private/Public insurance | 78/18 | \(\backslash\) | 12 | |
CGM use | Device (Dexcom/Medtronic) | 103/1 | \(\backslash\) | 4 |
Total duration of data (days) | 118325 | \(\backslash\) | \(\backslash\) | |
Duration of data/participant (days) | 1096 ± 580 | 272 - 2412 | \(\backslash\) | |
Total days with no CGM use | 32931 | \(\backslash\) | \(\backslash\) | |
Total days with high CGM use | 76435 | \(\backslash\) | \(\backslash\) | |
Blood glucose data | Total BG samples | 22,985,747 | \(\backslash\) | \(\backslash\) |
Number of BG samples/participant | 212,831 ± 139,929 | 7,721 - 601,407 | \(\backslash\) | |
Mean blood glucose/day (mg/dL) | 195.2 ± 49.2 | 70.4 - 401.0 | \(\backslash\) | |
Mean time in range/day (%) | 47.0 ± 24.1 | 0 - 100 | \(\backslash\) |
